论文部分内容阅读
2001年日本市场药品销售额为476亿美元,较2000年增长4%,同期美国市场药品销售额为1321亿美元。预计2002～2005年期间,日本制药市场的年平均增长率为2%,而同期美国市场每年将增长12%。在销售收入、研发能力及市场的开拓能力上,大多数日本制药企业与欧美大型制药企业相比有较大差距。武田化工有限公司是目前日本最大的制药企业,2001年研发费用为8.25亿美元,与之相比,辉瑞公司去年研发
In 2001, the sales volume of medicine in the Japanese market was 47.6 billion U.S. dollars, up 4% over 2000, while the pharmaceutical sales in the U.S. market were 132.1 billion U.S. dollars. It is estimated that the average annual growth rate of the Japanese pharmaceutical market will be 2% between 2002 and 2005, while the U.S. market will grow 12% annually. In terms of sales revenue, R & D capability and market development ability, most Japanese pharmaceutical companies have a big gap compared with large pharmaceutical companies in Europe and the United States. Takeda Chemical Co., Ltd. is currently the largest pharmaceutical company in Japan, R & D costs in 2001 was 825 million US dollars, compared with the Pfizer last year, research and development